RH SEC Filings

Citadel-related entities and Kenneth Griffin reported shared beneficial ownership in RH common stock totaling up to 700,845 shares, representing approximately 3.7% of RH's outstanding shares. The Schedule 13G is a joint filing by Citadel Securities GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC, and Kenneth Griffin. Reported holdings range from 859 shares for certain advisory entities to 699,986 shares for some Citadel entities, with Citadel Securities LLC holding 599,644 shares (3.2%). All reported positions are shared voting and dispositive power; no sole voting or sole dispositive power was claimed.

Form 144 notice for RH (common stock): The filing notifies a proposed sale of 2,000 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $472,259.40. The company’s outstanding shares are reported as 18,745,070. The securities were acquired on 04/11/2024 via restricted stock vesting under a registered plan and were received as compensation. The filer reports no sales in the past three months and affirms they are not aware of undisclosed material adverse information about the issuer.

Mark S. Demilio, an RH director, exercised a fully vested stock option to acquire 20,000 shares on 09/16/2025 at an exercise price of $38.04 per share. The reporting shows 20,000 underlying shares from the option and a total of 32,717 shares beneficially owned directly after the transactions. The filing also reports 3,298 shares withheld by the company in settlement of taxes from the option exercise and additional indirect holdings: 9,914 shares held by The Mark S. Demilio Revocable Trust and 19,425 shares held by The Theresa E. Demilio 2012 Family Trust, of which Mr. Demilio is a beneficiary and co-trustee.

RH disclosed selected financial and corporate items in its Quarterly Report on Form 10-Q. The company reported 18,744,120 shares outstanding as of August 2, 2025 (18,726,116 as of February 1, 2025). It completed a business acquisition for $32 million funded from cash and recorded the transaction as a business combination under ASC 805. The company has a promissory note of $16 million maturing September 9, 2032, carrying a fixed interest rate of 5.37% until September 15, 2027, then resetting to five-year Treasury plus 2.00% subject to a 3.00% floor; the note is secured by Member LLC assets with no recourse to RH general assets.

RH disclosed liquidity arrangements including an asset-based lending (ABL) facility with $600 million capacity (with $300 million accordion to $900 million), separate availability for certain subsidiaries, and compliance with a fixed charge coverage ratio covenant of 1.0 as of August 2, 2025. The filing notes variable-rate exposure on borrowings, term loan tranches maturing October 20, 2028, equity method investments in two European entities, payment obligations under a Financing Program (approximately $20 million and $35 million referenced), and uncertainty around legal contingencies and tax law changes related to OECD Pillar II with no material tax impact for the periods presented.

Citadel-related entities and Kenneth Griffin report ownership of RH common stock totaling about 752,232 shares, representing approximately 4.0% of RH's outstanding shares. The Schedule 13G/A discloses that Citadel Securities LLC may be deemed to beneficially own 646,563 shares (3.5%), while Citadel Securities Group LP and Citadel Securities GP LLC each may be deemed to own 752,232 shares (4.0%). Smaller holdings of 10 shares are reported for several affiliated entities. The filing states these holdings are not intended to influence control of the issuer and are jointly filed by multiple Citadel-related reporting persons.

On 06/26/2025, RH (ticker: RH) filed a Form 4 reporting that director Kathleen C. Mitic received an award of 670 shares of RH common stock at a cost basis of $0.00. The filing states that the restricted stock will vest in full one year from the grant date. After the grant, Mitic’s direct beneficial ownership rises to 12,056 shares. No sales, derivative securities, or Rule 10b5-1 plan transactions were disclosed.